Financial News

Recent Quotes
My Watchlist
Indicators
Motherlode Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Corvus Pharma Com (NQ: CRVS )

4.040 USD +0.150 (+3.86%)
Streaming Delayed Price Updated: 2:05 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Corvus Pharma Com

< Previous 1 2 3 4 5 6 7 8 9 Next >
Corvus Presents New Data on its Investigational ITK Inhibitor CPI-818 at the American Society of Hematology (ASH) Annual Meeting & Exposition
From GlobeNewswire News Releases
Corvus Announces Upcoming CPI-818 Data Presentations at the American Society of Hematology (ASH) Annual Meeting & Exposition
Includes updated data from CPI-818 phase 1/1b trial and pre-clinical results supporting use in autoimmune lymphoproliferative syndrome (ALPS) 
From GlobeNewswire News Releases
Are These The Best Penny Stocks To Buy Now? 5 Biotech Stocks To Know
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
The Week Ahead In Biotech: Hematology Conference Gets Underway, Vanda And BioCryst Await FDA Decisions
Biotech stocks had a rather uneventful week, as the sector was seen mostly flatlining amid light trading volume ahead of the ... 
Tags Pharma Stocks MBIO Biotech
From Benzinga
Corvus Hosting R&D Symposium on November 12 to Highlight COVID-19 Program and Updated Study Data Presented at SITC Annual Meeting
From GlobeNewswire News Releases
Corvus Completes Enrollment in Phase 1 Study of CPI-006 for Patients with COVID-19 and Presents Study Data at 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
From GlobeNewswire News Releases
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ... 
Tags VIVO RETA MTCR
From Benzinga
Corvus Pharmaceuticals COVID-19 Abstract Selected for “Hot Topic” Oral Session at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Company to host R&D Symposium webcast on November 12, 2020 at 11:00 am ET to highlight COVID-19 program and provide updates on its cancer programs 
From GlobeNewswire News Releases
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2020 Financial Results
From GlobeNewswire News Releases
Corvus Pharmaceuticals to Present Updated Data from its Clinical Trial of CPI-006 for Patients with COVID-19 at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Company to host R&D Symposium webcast November 12, 2020 at 11:00 am ET to highlight COVID-19 program and provide updates on its cancer programs 
From GlobeNewswire News Releases
Week In Review: $1.5 Billion Total In Week's China Deals
Everest Medicines of Shanghai completed a $451 million IPO in Hong Kong to develop its portfolio of eight assets in-licensed for China development. The company's stock climbed 32% in its first trading... 
Tags Pharma/Biotech Stocks / Equities Healthcare
From Blogs - TalkMarkets
Week in Review: $1.5 Billion Total in Week's China Deals
Deals and Financings   Everest Medicines of Shanghai completed a $451 million IPO in Hong Kong to develop eight assets in-licensed for China development; Genor Biopharma of Shanghai raised $371 million... 
From ChinaBio® Today
58 Biggest Movers From Yesterday
Gainers Pioneer Power Solutions (NASDAQ: PPSI) shares climbed 205.7% to close at $4.80 on Tuesday. Electro-Sensors, Inc. ... 
Tags SOL ELSE CHCI
From Benzinga
10 Biggest Price Target Changes For Tuesday
JP Morgan boosted Advance Auto Parts, Inc. (NYSE: AAP) price target from $183 to $190. Advance Auto Parts shares rose 0.1% to ... 
Tags Pre/Market Outlook IOVA Penny Stocks
From Benzinga
62 Biggest Movers From Yesterday
Gainers Westwater Resources, Inc. (NASDAQ: WWR) shares surged 87.3% to close at $8.28 on Monday after surging 49% on Friday. The ... 
Tags NCMI EPR CINF
From Benzinga
Mid-Afternoon Market Update: Dow Surges 350 Points; Eidos Therapeutics Shares Spike Higher
Toward the end of trading Monday, the Dow traded up 1.27% to 28,035 while the NASDAQ rose 1.67% to 11,260.24. The S&P also rose, ... 
Tags Mid/Afternoon Market Update Commodities Eurozone
From Benzinga
12 Healthcare Stocks Moving In Monday's Intraday Session
Gainers Artelo Biosciences (NASDAQ:ARTL) stock increased by 61.62% to $1.39 during Monday's regular session. Trading volume ... 
Tags LMNL IMNM Top Gainers
From Benzinga
Mid-Day Market Update: Crude Oil Jumps 7%; Nam Tai Property Shares Plunge
Midway through trading Monday, the Dow traded up 1.31% to 28045.99 while the NASDAQ rose 1.68% to 11260.83. The S&P also rose, ... 
Tags Market News Intraday Update DPW
From Benzinga
50 Stocks Moving In Monday's Mid-Day Session
Gainers MyoKardia, Inc. (NASDAQ: MYOK) shares climbed 58.2% to $220.80 after Bristol-Myers Squibb announced a multi-billion ... 
Tags EPR CINF JOE
From Benzinga
Why Corvus Pharmaceuticals Is Trading Higher Today
Corvus Pharmaceuticals (NASDAQ: CRVS) shares are trading higher on Monday after the company announced positive early results from a ... 
Tags Movers Market News CRVS
From Benzinga
Looking Into Corvus Pharmaceuticals's Return On Capital Employed
During Q2, Corvus Pharmaceuticals (NASDAQ: CRVS) brought in sales totaling $0.00. However, earnings decreased 18.86%, resulting in a ... 
Tags Health Care News Benzinga
From Benzinga
Thinking about buying stock in Enlivex Therapeutics, Corvus Pharmaceuticals, Livent Corp, Solid Biosciences, or Boxlight Corp?
InvestorsObserver issues critical PriceWatch Alerts for ENLV, CRVS, LTHM, SLDB, and BOXL. 
From PR Newswire
What Are The Best Penny Stocks To Buy Now? 5 Moving Premarket
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
12 Healthcare Stocks Moving In Monday's Pre-Market Session
Gainers MyoKardia (NASDAQ:MYOK) stock rose 58.13% to $220.76 during Monday's pre-market session. The company's market cap ... 
Tags AHPI IMGN NMTR
From Benzinga
Corvus Pharmaceuticals Announces Co-Founding of Angel Pharmaceuticals in China
From GlobeNewswire News Releases
New Data from Corvus Phase 1 Study of CPI-006 Continues to Support its Potential as a Treatment for COVID-19
From GlobeNewswire News Releases
Corvus Forms $106 Million China Subsidiary with China Rights to Four of its Assets
Corvus Pharma formed a China subsidiary, Angel Pharma, to develop its three clinical stage assets and one preclinical platform in China . Angel will have a post-money value of $106 million. Corus will... 
From ChinaBio® Today
New Data from Ciforadenant Phase 1b/2 Clinical Study Presented at ESMO Virtual Congress 2020
From GlobeNewswire News Releases
Corvus Pharmaceuticals Appoints Edith Mitchell, M.D., to Board of Directors
Dr. Mitchell adds significant experience in cancer care, research and healthcare delivery as the Company advances pipeline into later-stage clinical development 
From GlobeNewswire News Releases
61 Biggest Movers From Yesterday
Gainers Yield10 Bioscience Inc (NASDAQ: YTEN) shares jumped 53.8% to close at $6.69 on Thursday after HC Wainwright & Co. ... 
Tags LRN PDCE GTX
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback